Each small tick mark = 1 unit (0.01 mL)
In the NHIS, the overall prevalence was 500 per 100,000 population, and the prevalence in women was 865 per 100,000
The Coolest, Craziest Peptides (& Where To Get Them) With Kyal Van Der Leest In this deep dive, we explore the cutting-edge compounds that are pushing the boundaries of human performance
Tirzepatide, a dual GLP-1 and GIP receptor agonist, has transformed weight loss therapy for thousands of patients
Retatrutide shows the most impressive surrogate marker data of all three medications
If you have been curious about weight loss peptides but unsure where to start, the best next step is a conversation, not a purchase